This is the authors' abstract. We don't add key points for this paper.
Sir, Gitelman syndrome (GS), described by Gitelman et al. [1], is a rare autosomal recessive tubular disorder secondary to loss of function mutations in the Na–Cl co-transporter (NCCT) located in the apical membrane of distal convoluted tubule. The laboratory findings are characterized by hypokalaemia, hypomagnesaemia, hypocalciuria, hyperreninaemic hyperaldosteronism and metabolic alkalosis [2]. The clinical spectrum is wide, represented by chronic and severe fatigue, paresthesiae, cramps, transient episodes of muscle weakness and tetany [3]. Nevertheless, in some cases it can be asymptomatic, being diagnosed incidentally. In the past decade, the association between GS and CPPD deposition disease has been described by some authors [4, 5]. The CPPD disease is characterized by deposits of CPPD crystals within the hyaline or fibro-cartilage of the joints or in the periarticular soft tissues [6]. Less frequently, the pyrophosphate crystals are located in the peri-odontoid tissues of the cervical spine, generating periodic acute cervical pain associated with occasionally fever and biological inflammatory syndrome. This clinical entity is noted as crowned dens syndrome (CDS) [7]. We describe an unusual case of GS associated with CPPD disease and CDS. To the best of our knowledge, this is the first report in literature that documents the association among these three conditions. A 49-year-old Caucasian woman was admitted at the age of 39 years to the Endocrinology Department of the Università Politecnica delle Marche, for a history of transient tetanic episodes and carpo-pedal spasm, muscular weakness and hand paresthesiae. Laboratory analysis revealed severe hypomagnesaemia [0.5 mg/dl; normal value (nv) 1.4–2.4 mg/dl], hypokalaemia (2.9 mmol/l; nv 3.5–5 mmol/l), hypocalciuria (9.6 mg/24 h; nv 100–300 mg/24 h), metabolic alkalosis (pH 7.6 and bicarbonate 31.8 mmol/l) and hyperreninaemic hyperaldosteronism in both the supine and upright position. Genetic testing showed two different mutations in the NCCT gene. The diagnosis of GS was made. Treatment with high doses of oral magnesium carbonate (average dose 9 g/day) and potassium (70 mmol/day) was begun; however, electrolyte balance and clinical symptoms remained poorly controlled. Therefore, repeated intravenous infusions of potassium and magnesium were administrated with a discrete response. Laboratory values at different times are shown in Table 1. Laboratory values at different times of evolution aThe reported values are the most representative for each year. ND: not determined. Laboratory values at different times of evolution aThe reported values are the most representative for each year. ND: not determined. Over the following 10 years, the patient developed acute episodes of arthritis of the wrists, elbows and knees. She was referred to our Rheumatology Department. Laboratory data revealed an increase in the ESR and CRP, hypomagnesaemia (0.9 mg/dl), hypokalaemia (3.3 mmol/l) and hypocalciuria (26.6 mg/24 h). Joint X-ray showed huge calcific deposits in the menisci of both knees and in the triangular cartilage of both wrists (Fig. 1A). Sonographic examination documented the presence of marked enlargement of the suprapatellar pouch of the right knee and confirmed the presence of widespread calcifications (Fig. 1B and C). Knee arthrocentesis was carried out and CPPD crystals were observed in the SF by polarizing light microscopy. After 2 weeks, she complained of acute neck pain associated with marked neck stiffness. X-ray of the cervical spine was normal, whereas a CT of cervical spine showed diffuse peri-odontoid calcification and a small erosion of the odontoid process (Fig. 1D–F). The diagnosis of CDS was made. Therapy with colchicine (2 mg/day) was started, but after three doses the patient developed severe diarrhoea. Although other therapeutic regimens with colchicine were tried, profuse diarrhoea persisted. Thus, colchicine was stopped. Currently, the attacks of synovitis and neck pain recur every 2–3 weeks. The therapy consist in acetaminophen, NSAID and short cycles of 6-methylprednisolone with satisfactory control of musculoskeletal symptoms. Conventional radiography of the antero-posterior view of right knee (A) showing massive calcifications within both medial (curved arrow) and lateral menisci (white arrow). Sonographic examination on suprapatellar longitudinal view with the knee in maximal flexion (B) and longitudinal lateral view with the knee in neutral position (C) showing CPPD crystal deposits in both the femoral hyaline cartilage (white arrow) and lateral meniscus (curved arrow), respectively. Cervical CT scan in axial (D), sagittal (E) and coronal (F) multiplanar reconstructions. Note the presence of diffuse calcified deposits of the transverse ligament of the atlas (black arrow head), cruciate ligament (white arrow head) and surrounding the odontoid process (empty arrow head) with associated sub-chondral erosions (black arrow). f: femur; p: patella; t: tibia; op: odontoid process. GS is an autosomal recessive salt-losing renal tubulopathy that is characterized by hypomagnesaemia, hypocalciuria and secondary hyperaldosteronism, which is responsible for hypokalaemia and metabolic alkalosis [1, 3]. The prevalence ranges from 1.2 to 25 cases/million [2, 8]. CPPD deposition disease is an idiopathic condition, frequently present in the elderly population. There is evidence that it may be familial or occur as a consequence of endocrine or associated metabolic conditions such as hemochromatosis, hypophosphatasia, hyperparathyroidism, ocronosis and hypomagnesaemia [9]. Some authors have described CPPD deposition disease as a possible consequence of GS [4, 5], as a typical example of hypomagnesaemia-induced CPPD deposition disease. The role of hypomagnesaemia in the development of CPPD deposition disease is not fully understood. It is known that an excess of inorganic pyrophosphates is the main precursor for CPPD crystal nucleation. Because the magnesium is a necessary cofactor for numerous enzymes such as pyrophosphatases and considering the fact that it increases the solubility of CPPD crystals, low levels of magnesium could induce CPPD deposition disease by raising IA inorganic pyrophosphates and/or reducing the saturation product of CPPD crystals [10]. Treatment of GS commonly includes potassium and magnesium supplementation: the magnesium not only corrects the hypomagnesaemia but also improves the hypokalaemia [11]. In some patients with CPPD deposition disease secondary to hypomagnesaemia, the stabilization of magnesium and potassium levels can reduce the deposition of CPPD crystals in the synovium and SF, reducing the frequency of attacks of articular pain [5]. In other cases, treatment of hypomagnesaemia can be difficult because oral supplementation alone is inadequate, and it has a laxative effect. In fact, in our patient, repeated intravenous infusions of magnesium and potassium were required. Moreover, the association with colchicine induced profuse diarrhoea. The development of acute neck pain and stiffness inducted to perform a CT scan of the cervical spine, which showed diffuse calcifications of the peri-odontoid tissues (transverse ligament of the atlas and cruciate ligament), indicative of CDS. The term CDS was first proposed by Bouvet et al. in 1985 [7]. In a recent report conducted by Salaffi et al. [12], in 25 out of 49 patients (51%) affected by CPPD deposition disease, axial CT scanning of the cervico–occipital junction revealed periodontoid calcification. The mean age in this study was 70.4 years. Our patient is notably younger, probably because the CPPD deposition disease was secondary to GS. Further cases are needed in order to improve knowledge of the pathophysiology and prevalence of this entity in patients with CPPD deposition disease secondary to hypomagnesaemia. We suggest that rheumatologists bear in mind the clinical association between GS, CPPD and CDS in order to avoid misinterpretations and carry out the correct clinical approach. Particular attention must be paid to young adult patients with a history of hypomagnesaemia and/or hypokalaemia associated with musculoskeletal symptoms, frequently reported in rheumatologic daily clinical practice. Disclosure statement: The authors have declared no conflicts of interest.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gutiérrez et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: